Crossmark

Ketamine for comorbid treatment-resistant depression and substance use disorders: balancing risks and opportunities

Crossref DOI link: https://doi.org/10.1007/s43440-026-00843-9

Published Online: 2026-03-11

Published Print: 2026-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Brody, Benjamin D. https://orcid.org/0000-0001-6558-7293
Kanellopoulos, Dora https://orcid.org/0000-0002-2676-2957
License Information

Text and Data Mining valid from 2026-03-11

Version of Record valid from 2026-03-11
More Information

Article History

Received: 2 August 2025

Revised: 13 February 2026

Accepted: 18 February 2026

First Online: 11 March 2026

Declarations

:

: The authors declare no competing interests.